Sponsor

Portland VA Medical Center

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Portland VA Medical Center appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning DeficitsNCT06728774 · lead sponsor · 2025-05-01
RECRUITING
Comprehensive Fall Prevention and Detection in Multiple SclerosisNCT02583386 · lead sponsor · 2016-04-01
COMPLETED
Assistive Device Training in Multiple SclerosisNCT02408718 · lead sponsor · 2015-07-01
COMPLETED
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA MethylationNCT01265953 · lead sponsor · 2011-07-01
COMPLETED
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple SclerosisNCT00997438 · lead sponsor · 2010-08-01
COMPLETED
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate CancerNCT01013129 · lead sponsor · 2008-07-01
COMPLETED
Noninvasive Blood Glucose Monitoring Using Otoacoustic EmissionsNCT01073137 · lead sponsor · 2006-06-01
UNKNOWN
Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of ParoxetineNCT00357045 · lead sponsor
COMPLETED
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.NCT05422911 · collaborator · 2022-08-31
RECRUITING
Aerobic Exercise for Remyelination in Multiple SclerosisNCT04539002 · collaborator · 2021-04-29
COMPLETED
A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MSNCT04145934 · collaborator · 2020-02-06
COMPLETED
Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)NCT03716258 · collaborator · 2019-01-01
TERMINATED
North American Prodromal Synucleinopathy ConsortiumNCT03623672 · collaborator · 2018-08-29
ENROLLING_BY_INVITATION
Exercise Program Among Lung Cancer DyadsNCT03649737 · collaborator · 2018-07-16
COMPLETED
Measuring Cortisol Levels in Persons With Parkinson's (PD)NCT02727270 · collaborator · 2016-06-01
COMPLETED
Video Based Mindfulness Based Stress ReductionNCT02705586 · collaborator · 2016-03-01
COMPLETED
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced DyskinesiaNCT02589340 · collaborator · 2016-01-01
TERMINATED
Methylphenidate to Improve Balance and Walking in MSNCT01896700 · collaborator · 2013-07-01
COMPLETED
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerNCT01780701 · collaborator · 2013-01-01
COMPLETED

Drugs studied in this sponsor's trials

7 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Portland VA Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo2
abiraterone acetate1
apalutamide1
buspirone1
enzalutamide1
methylphenidate1
paroxetine1

Sponsor roles

collaborator11
lead sponsor8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.